These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31787337)

  • 1. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
    Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
    Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.
    Gidwani K; Huhtinen K; Kekki H; van Vliet S; Hynninen J; Koivuviita N; Perheentupa A; Poutanen M; Auranen A; Grenman S; Lamminmäki U; Carpen O; van Kooyk Y; Pettersson K
    Clin Chem; 2016 Oct; 62(10):1390-400. PubMed ID: 27540033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
    Terävä J; Tiainen L; Lamminmäki U; Kellokumpu-Lehtinen PL; Pettersson K; Gidwani K
    PLoS One; 2019; 14(7):e0219480. PubMed ID: 31344060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3.
    Ekman M; Salminen T; Raiko K; Soukka T; Gidwani K; Martiskainen I
    Anal Bioanal Chem; 2024 May; 416(13):3251-3260. PubMed ID: 38584178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer.
    Jain S; Nadeem N; Ulfenborg B; Mäkelä M; Ruma SA; Terävä J; Huhtinen K; Leivo J; Kristjansdottir B; Pettersson K; Sundfeldt K; Gidwani K
    Int J Cancer; 2022 Oct; 151(7):1175-1184. PubMed ID: 35531590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection.
    Kekki H; Peltola M; van Vliet S; Bangma C; van Kooyk Y; Pettersson K
    Clin Biochem; 2017 Jan; 50(1-2):54-61. PubMed ID: 27818346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
    Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
    Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin-nanoparticle concept for free PSA glycovariant providing superior cancer specificity.
    Kekki H; Montoya Perez I; Taimen P; Boström PJ; Gidwani K; Pettersson K
    Clin Chim Acta; 2024 Jun; 559():119689. PubMed ID: 38677453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
    Gidwani K; Nadeem N; Huhtinen K; Kekki H; Heinosalo T; Hynninen J; Perheentupa A; Poutanen M; Carpen O; Pettersson K; Lamminmäki U
    J Appl Lab Med; 2019 Nov; 4(3):299-310. PubMed ID: 31659068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
    Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation markers in cancer.
    Silsirivanit A
    Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125.
    Bayoumy S; Hyytiä H; Leivo J; Talha SM; Huhtinen K; Poutanen M; Hynninen J; Perheentupa A; Lamminmäki U; Gidwani K; Pettersson K
    Commun Biol; 2020 Aug; 3(1):460. PubMed ID: 32826955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of glycan specific lectin based immunoassay for detection of prostate specific antigen.
    Bhanushali PB; Badgujar SB; Tripathi MM; Gupta S; Murthy V; Krishnasastry MV; Puri CP
    Int J Biol Macromol; 2016 May; 86():468-80. PubMed ID: 26840176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum.
    Terävä J; Verhassel A; Botti O; Islam MK; Leivo J; Wittfooth S; Härkönen P; Pettersson K; Gidwani K
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1540. PubMed ID: 34423573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles.
    Islam MK; Syed P; Lehtinen L; Leivo J; Gidwani K; Wittfooth S; Pettersson K; Lamminmäki U
    Sci Rep; 2019 Jul; 9(1):10038. PubMed ID: 31296879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
    Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
    [No Abstract]   [Full Text] [Related]  

  • 18. Lectin-based lateral flow assay: proof-of-concept.
    Damborský P; Koczula KM; Gallotta A; Katrlík J
    Analyst; 2016 Nov; 141(23):6444-6448. PubMed ID: 27767199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay.
    Huo Q
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):259-65. PubMed ID: 20392611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
    Llop E; Peracaula R
    Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.